Abstract

For patients with congenital long-QT syndrome (LQTS), beta-blockers are considered first-line therapy; however, their efficacy has not been

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call